Dr. Walter Liszewski, MD
Dermatology (Dermatology Physician)
676 N Saint Clair St Ste 1600
Chicago, IL 60611
Who else practices at this address →
Cook County includes primary care (3% of residents) and mental health (4% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- Tulane University School of Medicine (2015)
- Years since graduation
- 11
- In the NPI registry since
- 2015
- Medicare patients seen, 2024
- 449
Licensed in Illinois since 2019, according to the Illinois Department of Financial and Professional Regulation. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2015Medical school: Tulane University School of Medicine
- 2015Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Dermatology Physician primary
IL license 036.149833 (first issued 2019; active) · MN license 62406 - Student in an Organized Health Care Education/Training Program
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Northwestern Medicine Central Dupage Hospital Winfield, IL
- Northwestern Memorial Hospital Chicago, IL
Medical groups
- Northwestern Medical Faculty Foundation (4,503 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 449
- Services billed
- 5,681
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Test for allergy using skin patch | 4,172 | 40 |
| Destruction of precancer skin growth, 2-14 growths | 388 | 89 |
| Established patient office or other outpatient visit, 30-39 minutes | 289 | 236 |
| Established patient office or other outpatient visit, 20-29 minutes | 205 | 179 |
| Destruction of precancer skin growth, 1 growth | 145 | 124 |
| Biopsy of related skin growth, first growth | 81 | 74 |
| New patient office or other outpatient visit, 45-59 minutes | 67 | 67 |
| New patient office or other outpatient visit, 30-44 minutes | 51 | 51 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 28 | 11 |
| Destruction of skin growth, 1-14 growths | 24 | 23 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 14 companies reported 234 payments worth $303,912 in total to this clinician.
| Lilly USA, LLC | $100,391 |
|---|---|
| Genzyme Corporation | $84,968 |
| Galderma Laboratories, L.P. | $54,017 |
| AbbVie Inc. | $16,511 |
| Leo Pharma Inc. | $13,507 |
| Novartis Pharmaceuticals Corporation | $10,094 |
| Arcutis Biotherapeutics, Inc. | $10,015 |
| Kowa Pharmaceuticals America, Inc. | $8,043 |
| Compensation for services other than consulting (speaking, faculty) | $218,470 |
|---|---|
| Consulting Fee | $60,451 |
| Travel and Lodging | $18,899 |
| Food and Beverage | $6,092 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Genzyme Corporation Oct 4, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $11,938 |
| Genzyme Corporation Oct 18, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $11,938 |
| Genzyme Corporation Nov 2, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $11,938 |
| Galderma Laboratories, L.P. Dec 18, 2025 | Consulting Fee NEMLUVIO · DERMATITIS | $11,475 |
| Genzyme Corporation Nov 20, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $10,028 |
| Genzyme Corporation Dec 4, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $10,028 |
| Galderma Laboratories, L.P. Oct 27, 2025 | Compensation for services other than consulting (speaking, faculty) NEMLUVIO · DERMATITIS | $9,800 |
| Novartis Pharmaceuticals Corporation Jun 21, 2025 | Consulting Fee | $8,000 |
| Lilly USA, LLC Jun 12, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $6,400 |
| Genzyme Corporation Nov 1, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $5,253 |
All 131 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Leo Pharma Inc. Dec 23, 2025 | Compensation for services other than consulting (speaking, faculty) ANZUPGO · DERMATOLOGY | $4,073 |
| Regeneron Pharmaceuticals, Inc. Dec 19, 2025 | Consulting Fee DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $3,820 |
| Regeneron Pharmaceuticals, Inc. Dec 19, 2025 | Consulting Fee DUPIXENT · IMMUNOLOGY AND INFLAMMATION | $1,910 |
| Galderma Laboratories, L.P. Dec 18, 2025 | Consulting Fee NEMLUVIO · DERMATITIS | $11,475 |
| Genzyme Corporation Dec 16, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $4,298 |
| Genzyme Corporation Dec 16, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $4,298 |
| Lilly USA, LLC Dec 16, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $3,200 |
| Lilly USA, LLC Dec 16, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology | $1,200 |
| Galderma Laboratories, L.P. Dec 12, 2025 | Travel and Lodging NEMLUVIO · DERMATITIS · travel to BOSTON, MA · in-kind | $643 |
| Galderma Laboratories, L.P. Dec 12, 2025 | Travel and Lodging NEMLUVIO · DERMATITIS · travel to BOSTON, MA · in-kind | $248 |
| Kowa Pharmaceuticals America, Inc. Dec 11, 2025 | Travel and Lodging ZORYVE · DERMATOLOGY · travel to NAPERVILLE, IL | $425 |
| Galderma Laboratories, L.P. Dec 11, 2025 | Travel and Lodging NEMLUVIO · DERMATITIS · travel to CHICAGO, IL · in-kind | $206 |
| Genzyme Corporation Dec 10, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT; DUPIXENT · Immunology | $4,775 |
| Lilly USA, LLC Dec 10, 2025 | Travel and Lodging EBGLYSS · Immunology · travel to CHICAGO, IL | $6.41 |
| Galderma Laboratories, L.P. Dec 8, 2025 | Consulting Fee NEMLUVIO · DERMATITIS Company’s descriptionGalderma Global Comml Case-Based Learning Program | $3,000 |
| Genzyme Corporation Dec 4, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $10,028 |
| Kowa Pharmaceuticals America, Inc. Dec 4, 2025 | Compensation for services other than consulting (speaking, faculty) ZORYVE · DERMATOLOGY | $3,375 |
| Genzyme Corporation Dec 4, 2025 | Travel and Lodging DUPIXENT · Immunology · travel to St. Louis, MO · in-kind | $588 |
| Galderma Laboratories, L.P. Dec 3, 2025 | Travel and Lodging NEMLUVIO · DERMATITIS · travel to CHICAGO, IL · in-kind | $26.71 |
| Galderma Laboratories, L.P. Dec 3, 2025 | Travel and Lodging NEMLUVIO · DERMATITIS · travel to CHICAGO, IL · in-kind | $9.50 |
| Galderma Laboratories, L.P. Dec 1, 2025 | Compensation for services other than consulting (speaking, faculty) NEMLUVIO · DERMATITIS | $3,600 |
| Galderma Laboratories, L.P. Nov 26, 2025 | Consulting Fee NEMLUVIO · DERMATITIS | $5,100 |
| Genzyme Corporation Nov 20, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $10,028 |
| Kowa Pharmaceuticals America, Inc. Nov 20, 2025 | Compensation for services other than consulting (speaking, faculty) ZORYVE · DERMATOLOGY | $3,375 |
| Genzyme Corporation Nov 20, 2025 | Travel and Lodging DUPIXENT · Immunology · travel to Eau Claire, WI · in-kind | $1,076 |
| Genzyme Corporation Nov 20, 2025 | Travel and Lodging DUPIXENT · Immunology · travel to Eau Claire, WI · in-kind | $224 |
| Genzyme Corporation Nov 20, 2025 | Travel and Lodging DUPIXENT · Immunology · travel to Eau Claire, WI · in-kind | $170 |
| Genzyme Corporation Nov 20, 2025 | Travel and Lodging DUPIXENT · Immunology · travel to Eau Claire, WI | $129 |
| Arcutis Biotherapeutics, Inc. Nov 14, 2025 | Consulting Fee Zoryve · Dermatology | $1,875 |
| Galderma Laboratories, L.P. Nov 12, 2025 | Consulting Fee NEMLUVIO · DERMATITIS | $2,500 |
| Lilly USA, LLC Nov 12, 2025 | Travel and Lodging EBGLYSS · Immunology · travel to BOERNE, TX | $459 |
| Leo Pharma Inc. Nov 6, 2025 | Compensation for services other than consulting (speaking, faculty) ANZUPGO · DERMATOLOGY | $2,263 |
| Genzyme Corporation Nov 2, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $11,938 |
| Genzyme Corporation Nov 2, 2025 | Travel and Lodging DUPIXENT · Immunology · travel to Orlando, FL | $435 |
| Genzyme Corporation Nov 1, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $5,253 |
| Genzyme Corporation Nov 1, 2025 | Travel and Lodging DUPIXENT · Immunology · travel to Chicago, IL · in-kind | $817 |
| Genzyme Corporation Nov 1, 2025 | Travel and Lodging DUPIXENT · Immunology · travel to Chicago, IL · in-kind | $359 |
| AbbVie Inc. Oct 28, 2025 | Travel and Lodging RINVOQ · IMMUNOLOGY · travel to CHESTERFIELD, MO · in-kind | $510 |
| Galderma Laboratories, L.P. Oct 27, 2025 | Compensation for services other than consulting (speaking, faculty) NEMLUVIO · DERMATITIS | $9,800 |
| Lilly USA, LLC Oct 23, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $3,200 |
| Lilly USA, LLC Oct 23, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $3,200 |
| Lilly USA, LLC Oct 23, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology | $2,800 |
| Lilly USA, LLC Oct 23, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology | $2,800 |
| Leo Pharma Inc. Oct 23, 2025 | Consulting Fee ANZUPGO; ADBRY · DERMATOLOGY | $109 |
| Leo Pharma Inc. Oct 23, 2025 | Consulting Fee ANZUPGO; ADBRY · DERMATOLOGY | $72.21 |
| Genzyme Corporation Oct 18, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $11,938 |
| Genzyme Corporation Oct 18, 2025 | Travel and Lodging DUPIXENT · Immunology · travel to Orlando, FL · in-kind | $612 |
| Genzyme Corporation Oct 18, 2025 | Travel and Lodging DUPIXENT · Immunology · travel to Orlando, FL | $269 |
| Genzyme Corporation Oct 18, 2025 | Travel and Lodging DUPIXENT · Immunology · travel to Orlando, FL · in-kind | $269 |
| Kowa Pharmaceuticals America, Inc. Oct 16, 2025 | Compensation for services other than consulting (speaking, faculty) ZORYVE · DERMATOLOGY | $750 |
| Lilly USA, LLC Oct 16, 2025 | Travel and Lodging travel to SAN ANTONIO, TX · in-kind | $112 |
| Galderma Laboratories, L.P. Oct 10, 2025 | Travel and Lodging NEMLUVIO · DERMATITIS · travel to NEW ORLEANS, LA · in-kind | $466 |
| Genzyme Corporation Oct 4, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $11,938 |
| Genzyme Corporation Oct 4, 2025 | Travel and Lodging DUPIXENT · Immunology · travel to Boston, MA · in-kind | $267 |
| Genzyme Corporation Oct 4, 2025 | Travel and Lodging DUPIXENT · Immunology · travel to Boston, MA | $207 |
| Leo Pharma Inc. Oct 2, 2025 | Consulting Fee ANZUPGO; ADBRY · DERMATOLOGY | $3,500 |
| Galderma Laboratories, L.P. Sep 29, 2025 | Compensation for services other than consulting (speaking, faculty) NEMLUVIO · DERMATITIS | $2,400 |
| AbbVie Inc. Sep 8, 2025 | Compensation for services other than consulting (speaking, faculty) RINVOQ · IMMUNOLOGY | $4,900 |
| AbbVie Inc. Sep 8, 2025 | Compensation for services other than consulting (speaking, faculty) RINVOQ · IMMUNOLOGY | $3,500 |
| Galderma Laboratories, L.P. Aug 27, 2025 | Consulting Fee NEMLUVIO · DERMATITIS | $2,500 |
| AbbVie Inc. Aug 13, 2025 | Travel and Lodging RINVOQ · IMMUNOLOGY · travel to CINCINNATI, OH · in-kind | $578 |
| AbbVie Inc. Aug 13, 2025 | Travel and Lodging RINVOQ · IMMUNOLOGY · travel to CINCINNATI, OH · in-kind | $312 |
| Arcutis Biotherapeutics, Inc. Aug 9, 2025 | Consulting Fee Zoryve · Dermatology | $4,500 |
| Galderma Laboratories, L.P. Aug 1, 2025 | Compensation for services other than consulting (speaking, faculty) NEMLUVIO · DERMATITIS | $600 |
| Genzyme Corporation Jul 24, 2025 | Compensation for services other than consulting (speaking, faculty) DUPIXENT · Immunology | $4,340 |
| Lilly USA, LLC Jul 1, 2025 | Travel and Lodging EBGLYSS · Immunology · travel to NEW ORLEANS, LA | $251 |
| Lilly USA, LLC Jun 27, 2025 | Travel and Lodging EBGLYSS · Immunology · travel to IRVING, TX | $207 |
| Lilly USA, LLC Jun 26, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $3,200 |
| Lilly USA, LLC Jun 26, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology | $2,800 |
| Lilly USA, LLC Jun 24, 2025 | Travel and Lodging EBGLYSS · Immunology · travel to ROLLING MEADOWS, IL | $159 |
| Lilly USA, LLC Jun 23, 2025 | Travel and Lodging EBGLYSS · Immunology · travel to PARK RIDGE, IL | $81.00 |
| Novartis Pharmaceuticals Corporation Jun 21, 2025 | Consulting Fee | $8,000 |
| Novartis Pharmaceuticals Corporation Jun 21, 2025 | Travel and Lodging travel to DENVER, CO | $489 |
| Novartis Pharmaceuticals Corporation Jun 21, 2025 | Travel and Lodging travel to DENVER, CO · in-kind | $300 |
| Novartis Pharmaceuticals Corporation Jun 20, 2025 | Travel and Lodging COSENTYX · Dermatology · travel to Denver, CO · in-kind | $619 |
| Lilly USA, LLC Jun 16, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $3,200 |
| Lilly USA, LLC Jun 13, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $3,200 |
| Lilly USA, LLC Jun 13, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology | $2,000 |
| Lilly USA, LLC Jun 12, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $6,400 |
| Lilly USA, LLC Jun 5, 2025 | Travel and Lodging travel to IRVING, IL · in-kind | $341 |
| Leo Pharma Inc. Jun 4, 2025 | Consulting Fee ANZUPGO · DERMATOLOGY | $2,715 |
| Lilly USA, LLC May 29, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $1,600 |
| Galderma Laboratories, L.P. May 16, 2025 | Travel and Lodging NEMLUVIO · DERMATITIS · travel to CHICAGO, IL · in-kind | $39.35 |
| Galderma Laboratories, L.P. May 16, 2025 | Travel and Lodging NEMLUVIO · DERMATITIS · travel to CHICAGO, IL · in-kind | $9.25 |
| Lilly USA, LLC May 12, 2025 | Travel and Lodging EBGLYSS · Immunology · travel to IOWA CITY, IA | $205 |
| Lilly USA, LLC May 12, 2025 | Travel and Lodging EBGLYSS · Immunology · travel to KIRKSVILLE, MO | $127 |
| Lilly USA, LLC May 5, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $3,200 |
| Lilly USA, LLC May 5, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology | $2,800 |
| Lilly USA, LLC Apr 29, 2025 | Travel and Lodging travel to IOWA CITY, IA · in-kind | $469 |
| Lilly USA, LLC Apr 29, 2025 | Travel and Lodging travel to IOWA CITY, IA · in-kind | $256 |
| Lilly USA, LLC Apr 29, 2025 | Travel and Lodging travel to IOWA CITY, IA · in-kind | $164 |
| Lilly USA, LLC Apr 28, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $3,200 |
| Lilly USA, LLC Apr 28, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $3,200 |
| Lilly USA, LLC Apr 28, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology | $2,800 |
| Lilly USA, LLC Apr 28, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology | $2,000 |
| Galderma Laboratories, L.P. Apr 25, 2025 | Compensation for services other than consulting (speaking, faculty) NEMLUVIO · DERMATITIS | $3,600 |
| Lilly USA, LLC Apr 25, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $3,200 |
| AbbVie Inc. Apr 25, 2025 | Travel and Lodging RINVOQ · IMMUNOLOGY · travel to CINCINNATI, OH · in-kind | $161 |
| Lilly USA, LLC Apr 24, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $3,200 |
| Lilly USA, LLC Apr 22, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $1,600 |
| Lilly USA, LLC Apr 22, 2025 | Travel and Lodging travel to KIRKSVILLE, MO · in-kind | $1,488 |
| Lilly USA, LLC Apr 22, 2025 | Travel and Lodging travel to KIRKSVILLE, MO · in-kind | $606 |
| Lilly USA, LLC Apr 22, 2025 | Travel and Lodging travel to KIRKSVILLE, MO · in-kind | $574 |
| Lilly USA, LLC Apr 21, 2025 | Travel and Lodging travel to GURNEE, IL · in-kind | $558 |
| AbbVie Inc. Apr 9, 2025 | Compensation for services other than consulting (speaking, faculty) RINVOQ · IMMUNOLOGY | $2,875 |
| Lilly USA, LLC Apr 7, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $3,200 |
| Lilly USA, LLC Apr 7, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $3,200 |
| Lilly USA, LLC Apr 7, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology | $2,000 |
| Lilly USA, LLC Apr 7, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology | $2,000 |
| Lilly USA, LLC Apr 3, 2025 | Travel and Lodging travel to CHAMPAIGN, IL · in-kind | $731 |
| Lilly USA, LLC Apr 3, 2025 | Travel and Lodging travel to CHAMPAIGN, IL · in-kind | $361 |
| AbbVie Inc. Mar 14, 2025 | Compensation for services other than consulting (speaking, faculty) RINVOQ · IMMUNOLOGY | $2,875 |
| Lilly USA, LLC Mar 11, 2025 | Travel and Lodging EBGLYSS · Immunology · travel to CHICAGO, IL | $47.58 |
| AbbVie Inc. Mar 4, 2025 | Travel and Lodging RINVOQ · IMMUNOLOGY · travel to CINCINNATI, OH · in-kind | $78.03 |
| Lilly USA, LLC Mar 3, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $3,200 |
| Lilly USA, LLC Jan 31, 2025 | Consulting Fee EBGLYSS · Immunology Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $3,200 |
| Lilly USA, LLC Jan 31, 2025 | Consulting Fee EBGLYSS · Immunology | $2,800 |
| Galderma Laboratories, L.P. Jan 29, 2025 | Compensation for services other than consulting (speaking, faculty) NEMLUVIO · DERMATITIS | $2,250 |
| Galderma Laboratories, L.P. Jan 23, 2025 | Travel and Lodging travel to CHICAGO, IL · in-kind | $49.00 |
| Galderma Laboratories, L.P. Jan 23, 2025 | Travel and Lodging travel to CHICAGO, IL · in-kind | $44.43 |
| Arcutis Biotherapeutics, Inc. Jan 22, 2025 | Consulting Fee Zoryve · Dermatology | $2,250 |
| Galderma Laboratories, L.P. Jan 17, 2025 | Compensation for services other than consulting (speaking, faculty) NEMLUVIO · DERMATITIS | $600 |
| Galderma Laboratories, L.P. Jan 15, 2025 | Compensation for services other than consulting (speaking, faculty) | $3,600 |
| Arcutis Biotherapeutics, Inc. Jan 12, 2025 | Consulting Fee Zoryve · Dermatology | $1,125 |
| Lilly USA, LLC Jan 9, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $1,600 |
| Lilly USA, LLC Jan 9, 2025 | Compensation for services other than consulting (speaking, faculty) EBGLYSS · Immunology Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $1,600 |
| Lilly USA, LLC Jan 7, 2025 | Travel and Lodging travel to KIRKSVILLE, MO · in-kind | $597 |
| Lilly USA, LLC Jan 7, 2025 | Travel and Lodging travel to KIRKSVILLE, MO · in-kind | $167 |
| Lilly USA, LLC Jan 2, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $3,200 |
| Lilly USA, LLC Jan 2, 2025 | Compensation for services other than consulting (speaking, faculty) | $1,200 |
| Lilly USA, LLC Jan 2, 2025 | Travel and Lodging travel to WINNETKA, IL | $300 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 8 industry-funded studies in 2025, from 3 companies. The companies reported $575,068 in research payments for these studies, mostly to the institutions running them.
- Upadacitinib as a novel treatment for refractory eyelid dermatitis
AbbVie Inc. - A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor
Sanofi US Services Inc. · Active, not recruiting · NCT06241118 - Dupilumab in Adolescent and Adult Skin of Color Participants: Open-label Moderate-to-severe Eczema Trial
Regeneron Pharmaceuticals, Inc. · Completed · NCT05590585 - A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
AbbVie Inc. · Active, not recruiting · NCT06389136 - M24-601 - A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab (Switch-Up)
AbbVie Inc. - A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab (Switch-Up)
AbbVie Inc. - A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy
AbbVie Inc. · Active, not recruiting · NCT05889182 - M23-698 - A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy (St…
AbbVie Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.